New York Cannabis Board Approves 20 New Adult-Use Licenses, Advances Medical Marijuana Rules and Equity Funding
- New York’s Cannabis Control Board approved 20 new adult-use marijuana licenses, bringing the total to 2,161 issued statewide, and advanced medical marijuana regulations, license renewals, and equity-focused business support initiatives.
- The board reviewed 79 adult-use license renewals, 38 amendments, and several applications under the CAURD program to promote stability and discipline in the maturing marijuana market.
- A $6 million Equity Business Development Grant Program was announced to support about 190 licensees, including CAURD businesses, distressed farmers, and service-disabled veterans, with grants up to $30,000 each, while also planning a pro bono legal support initiative for marijuana applicants and licensees.
- New York’s legal marijuana industry reported nearly $3 billion in retail sales with 599 dispensaries open, and equity applicants accounted for 56% of all adult-use licenses, reinforcing the state’s commitment to social and economic equity.
New York’s Cannabis Control Board has approved 20 new adult-use marijuana licenses while also moving forward with medical marijuana regulations, license renewals and new equity-focused business support initiatives, marking another major step in the continued expansion of the state’s legal market. According to the state, the newly approved licenses include two adult-use cultivators, three distributors, two microbusinesses, five processors, four retail dispensaries and four conditional adult-use retail dispensaries. With these additions, New York has now issued 2,161 adult-use licenses statewide.
The board also reviewed a broad range of additional actions during its March 5 meeting, including 79 adult-use renewals, 38 license amendments, four CAURD applications for licensure and 26 CAURD renewals. State officials said the actions are part of an effort to create a more stable and disciplined marijuana industry as the market continues to mature.
The board also approved adoption of medical marijuana regulations, although the release did not detail the specific provisions. Still, the action signals that state regulators are continuing to refine New York’s medical marijuana program alongside the rapidly growing adult-use market.
Officials also provided an update on the Equity Business Development Grant Program, a proposed $6 million initiative expected to reach about 190 licensees. Individual grants could be worth up to $30,000, with likely recipients including certain CAURD businesses, supply-side social and economic equity applicants, distressed farmers and service-disabled veterans. The state expects to select a third-party grant administrator in the second quarter of 2026, with the application portal projected to open in the fall.
In addition, the board received an update on a CUNY Law pro bono legal services initiative that would provide no-cost legal help to marijuana applicants and licensees, including one-on-one assistance, application support and virtual workshops. A full launch is expected in the second quarter.
New York’s legal marijuana market continues to post strong numbers. State officials said total reported retail sales have now reached $2.97 billion, with nearly $250 million generated during the first three weeks of February alone. There are now 599 legal dispensaries open across the state.
Equity participation remains a central part of the market’s makeup. Of all adult-use licenses issued so far, 56% have gone to social and economic equity applicants. Among the adult-use applications recommended for approval at the March 5 meeting, 44% were tied to equity applicants, including businesses identified as community disproportionately impacted, distressed farmer, minority-owned and women-owned.
The next Cannabis Control Board meeting is scheduled for April 2 in Buffalo.